Drupal.behaviors.print = function(context) {window.print();window.close();}>

MolecularMD Withdraws PMA for Leukemia CDx

September 18, 2012

MolecularMD Withdraws PMA for Leukemia CDx

By a GenomeWeb staff reporter

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories

MolecularMD Seeks FDA Clearance for Leukemia Drug Companion Dx

July 30, 2012 / GenomeWeb Daily News
Qiagen Submits EGFR Companion Dx to FDA

January 15, 2013 / GenomeWeb Daily News
Exact Sciences Submits First Module of PMA for Cologuard MDx Colorectal Cancer Screen to FDA

December 11, 2012 / GenomeWeb Daily News
Dako, Genentech Partner on Regulatory Submission of CDx for Second Breast Cancer Drug

May 1, 2012 / GenomeWeb Daily News
Qiagen Submits Second PMA for Therascreen KRAS Companion Dx

August 5, 2011 / GenomeWeb Daily News